Date | Title | Description | Source |
15.09.2022 | Find your next... | Calling all jobseekers! Don't miss Cambridge Network's Virtual Jobs & Careers Fair taking place ... | cambridgenetwo... |
01.08.2022 | Slone Partners... | “Thomas Schlumpberger is an experienced and admired leader in the POC diagnostics field where he has... | prweb.com/rele... |
29.09.2021 | Entreprene... | Entrepreneurial pathways to impact: spinning-out your research
Hosted by Cambridge Innovation Capit... | cic.vc/new... |
18.06.2021 | NeoGenomic... | NeoGenomics completes Inivata acquisition
Combining best-in-class liquid biopsy technology with lea... | cic.vc/new... |
25.05.2021 | Inivata An... | Inivata Announces Collaboration with F-star Therapeutics for the use of RaDaR™ Assay
RaDaR ctDNA li... | cic.vc/new... |
05.05.2021 | US giant s... | US giant swallows rest of Inivata in $415m acquisition
Business Weekly article | By Tony Quested
N... | cic.vc/new... |
05.05.2021 | Cambridge ... | Cambridge Innovation Capital announces acquisition of portfolio company Inivata
Cambridge Innovatio... | cic.vc/new... |
28.04.2021 | Inivata an... | Inivata and Agendia sign agreement for commercialization of RaDaR® MRD liquid biopsy assay in breast... | cic.vc/new... |
10.04.2021 | Inivata pr... | Inivata presents new data in support of its liquid biopsy technologies at AACR Virtual Annual Meetin... | cic.vc/new... |
09.03.2021 | FDA grants... | FDA Grants Breakthrough Device Designation for Inivata’s RaDaR™ Assay
Designation will help acceler... | cic.vc/new... |
09.02.2021 | Inivata raises... | Inivata, a leader in liquid biopsy, announced that it has raised $35 million (£25.7 million) in a se... | cambridgenetwo... |
09.02.2021 | Inivata raises... | Inivata raises $35 million in second close of Series C financing
09-02-2021
Inivata, a leader in l... | cambridgenetwo... |
04.02.2021 | Inivata ra... | Inivata raises $35 million in second close of Series C financing
Funds will accelerate clinical dev... | cic.vc/new... |
04.02.2021 | IP GROUP P... | Funds will accelerate clinical development of RaDaR™ minimal residual disease assay and commercializ... | marketscre... |
04.02.2021 | IP : Iniva... | Funds will accelerate clinical development of RaDaR™ minimal residual disease assay and commercializ... | marketscre... |
04.02.2021 | Inivata Ra... | Inivata Raises $35 million in Second Close of Series C Financing
Funds will accelerate clinical dev... | marketscre... |
27.01.2021 | A year in ... | Cambridge has always been at the forefront of innovation. As the leading venture capital investor in... | cic.vc/new... |
20.01.2021 | First pati... | First patients tested with InVisionFirst®-Lung in EORTC sponsored Phase II NSCLC study
Inivata’s In... | cic.vc/new... |
18.12.2020 | Inivata’s ... | Inivata’s liquid biopsy technology included in unique £10m research collaboration for early detectio... | cic.vc/new... |
26.11.2020 | Inivata Ap... | Inivata Appoints Dr. Alan Schafer as Chief Technology Officer
Inivata, a leader in liquid biopsy, t... | cic.vc/new... |
29.10.2020 | Inivata an... | Inivata announces collaboration with Maverick Therapeutics for use of RaDaR™ assay
RaDaR ctDNA liqu... | cic.vc/new... |
22.09.2020 | Inivata Ap... | Inivata Appoints Peter Collins as Chief Business Officer
Inivata, a leader in liquid biopsy, today ... | cic.vc/new... |
29.06.2020 | Inivata's ... | Inivata’s liquid biopsy test for advanced non-small cell lung cancer is now available through NeoGen... | cic.vc/new... |
22.06.2020 | Annual res... | Expansion to 30 portfolio companies and 46% increase in net asset value, reinforcing CIC’s position ... | cic.vc/new... |
26.05.2020 | Inivata An... | NeoGenomics will commercialize Inivata’s InVisionFirst®-Lung liquid biopsy test in the United States... | cic.vc/new... |
26.05.2020 | CIC portfolio ... | CIC portfolio company Inivata announces strategic collaboration and investment from NeoGenomics
26-... | cambridgenetwo... |
26.05.2020 | CIC portfolio ... | Cambridge Innovation Capital (CIC), the venture capital investor enabling visionaries to build globa... | cambridgenetwo... |
26.05.2020 | Portfolio ... | Cambridge Innovation Capital portfolio company Inivata announces strategic collaboration and investm... | cic.vc/new... |
24.04.2020 | Inivata launch... | Inivata, a Cambridge Innovation Capital portfolio company and a leader in liquid biopsy, announces t... | cambridgenetwo... |
24.04.2020 | Inivata launch... | Inivata launches RaDaR™ for the detection of residual disease and recurrence
24-04-2020
Inivata, a... | cambridgenetwo... |
23.04.2020 | Inivata la... | Personalized multi-tumor test provides potential new option for the rapid and sensitive identificati... | cic.vc/new... |
27.02.2020 | Inivata’s ... | Research Triangle Park, NC, USA and Cambridge, UK - Inivata, a leader in liquid biopsy, is pleased t... | cic.vc/new... |
16.04.2019 | Inivata, T... | Initial phase reveals high quality of samples through analysis using Inivata and Thermo Fisher Scien... | cic.vc/new... |
01.04.2019 | Term Sheet... | FACT VS. FICTION
Good morning, Term Sheet readers. I want to start today’s newsletter with an annou... | fortune.co... |
29.03.2019 | Inivata Comple... | Inivata, a Research Triangle Park, NC and Cambridge, UK-based leader in liquid biopsy, completed a S... | finsmes.com/20... |
29.03.2019 | Inivata Comple... | Inivata, a leader in liquid biopsy, today announces the completion of a Series B fundraising of $52.... | citybizlist.co... |
28.03.2019 | Promising... | This has been a big month for Inivata, the liquid biopsy company spun out from Cancer Resear... | endpts.com... |
28.03.2019 | CIC invests in... | CIC invests in Inivata’s £40 million series B funding round
28-03-2019
Cambridge Innovation Capita... | cambridgenetwo... |
28.03.2019 | Daily funding ... | BillionToOne raised $15M; Polyneuron Pharmaceuticals secured $22.6M;Prevail Therapeutics lands $50M
... | vator.tv/news/... |
28.03.2019 | CIC invest... | Funds will accelerate commercialisation of InVisionFirstTM-Lung Liquid Biopsy test and the developme... | cic.vc/new... |
07.03.2019 | Inivata pu... | Inivata, a leader in liquid biopsy, has announced the publication of results of a clinical validatio... | cic.vc/new... |
05.03.2019 | Inivata re... | Inivata, a leader in liquid biopsy, has announced that Palmetto GBA, a Medicare Administrative Contr... | cic.vc/new... |
24.09.2018 | Inivata pr... | InVisionFirst-Lung testing demonstrates excellent concordance with standard of care tissue profiling... | cic.vc/new... |
12.09.2018 | Inivata st... | Inivata, a leader in liquid biopsy, has strengthened its senior leadership team with the appointment... | cic.vc/new... |
19.03.2018 | Inivata pu... | Industry-leading sensitivity and specificity shown across all classes of genomic alterations relevan... | cic.vc/new... |
15.03.2018 | Inivata an... | Medstar and the MedStar Georgetown Cancer Institute to join the Inivata Knowledge Accumulation Netwo... | cic.vc/new... |
01.11.2017 | Inivata an... | Inivata has announced a strategic partnership with West Cancer Center that will see the organisation... | cic.vc/new... |
26.10.2017 | Inivata un... | Inivata has announced the formation of its Scientific Advisory Board (SAB) comprising global experts... | cic.vc/new... |
17.10.2017 | Inivata hi... | First data published using amplicon-based technology to detect ALK and ROS1 fusions
Highly sensitiv... | cic.vc/new... |
13.10.2017 | Inivata an... | Pilot study to test Genomics England samples using Inivata’s InVisionTM platform
Inivata is collabo... | cic.vc/new... |
27.09.2017 | Addario Lu... | InVision™ ctDNA liquid biopsy platform to be used to inform therapy following surgery of curative in... | cic.vc/new... |
08.09.2017 | Inivata ap... | Inivata has announced the appointment of Dr Jamie Platt as Chief Operations Officer. Jamie will be b... | cic.vc/new... |
07.09.2017 | Inivata an... | Inivata has announced a strategic partnership with Carolinas HealthCare System’s Levine Cancer Insti... | cic.vc/new... |
02.06.2017 | Inivata Hi... | Study shows InVision to be more sensitive than ddPCR and detects competing resistance mutations
Ini... | cic.vc/new... |
30.03.2017 | Inivata an... | Publication in Annals of Oncology shows benefit of osimertinib in EGFR-mutant non-small cell lung ca... | cic.vc/new... |
07.12.2016 | Inivata an... | Inivata will present data today with collaborators from Gustave Roussy at the 17th World Conference ... | cic.vc/new... |
05.12.2016 | Inivata Wi... | Inivata has been named as this year’s winner of the One Nucleus BioNewsRound Award, as announced at ... | cic.vc/new... |
03.11.2016 | Inivata an... | N-of-One to identify treatment strategies and clinical trial opportunities for patients based on Ini... | cic.vc/new... |
12.10.2016 | Inivata la... | Inivata has announced the launch of its US clinical validation study (INI-001) in non-small cell lun... | cic.vc/new... |
13.09.2016 | Inivata op... | Inivata has formally announced the establishment of its US site in Research Triangle Park, NC (RTP) ... | cic.vc/new... |
27.01.2016 | Inivata ‘liqui... | Inivata ‘liquid biopsy’ technology company raises £31.5M
27-01-2016
Clinical cancer genomics compa... | cambridgenetwo... |
26.01.2016 | Inivata Comple... | Inivata Limited, a Cambridge, UK-based clinical cancer genomics company employing the precision of c... | finsmes.com/20... |
23.09.2014 | Inivata raises... | Inivata raises £4m to improve cancer treatment through simple blood tests
23-09-2014
Inivata, a cl... | cambridgenetwo... |
23.09.2014 | Inivata raises... | Inivata, a clinical cancer genomics company focused on harnessing the potential of circulating tumou... | cambridgenetwo... |
23.09.2014 | Inivata Raises... | Inivata, a Cambridge, UK-based clinical cancer genomics company, raised £4m in funding.
The round w... | finsmes.com/20... |
23.09.2014 | Inivata ra... | Inivata raises £4m to realise the potential of ctDNA analysis to improve cancer treatment through si... | cic.vc/new... |